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ABSTRACT 
There has been great interest in the neurobiological substrate of the different dimensions of 
schizophrenia. This has largely focused on structural and functional changes while it has been 
acknowledged that there is a relation between pharmacological response and neurotransmitter 
alteration on these dimensions. Atypical anti psychotics which affect both positive and negative 
symptoms mediate their action predominantly through dopaminergic and serotonergic receptors. 
The current study extends this further looking at CSF amines. 37 drug naive first episode 
psychosis patients with the duration of illness less than 2 years were included. Patients were assessed 
with SAPS (Scale for Assessment of Positive Symptoms) and SANS (Scale for Assessment of 
Negative Symptoms). Lumbar puncture was done under sterile conditions and CSF was analyzed by 
HPLC for dopamine, serotonin and their metabolites. Mean CSF 5- HIAA was 25.35ng/dl. Mean CSF 
5 HT was 7.72 ng/dl. Mean CSFHVA was 36.99 ng/dl. Mean CSF 5-DA was 3.06 ng/dl. There was 
significant positive correlation between CSF5-HIAA and Negative and Disorganization dimensions. 
There was significant negative correlation between CSF HVA and Psychosis dimension. There is 
evidence to support that the implication of serotonin in Negative and Disorganization dimensions and 
the Serotonin- Dopamine interaction and dimensions of schizophrenia. 
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The etiology of the group of illnesses which in the myriad symptomatology of the disease. The 
are refered as 'schizophrenias' continues to be study of schizophrenia in terms of subtypes or 
unanswered in various aspects to the researchers syndromes can be categorical or dimensinal which 
in the field of psychiatry and it's allied sciences, assumes that a syndrome may be a continuum 
despite efforts over the past so many decades, (as oposed to an all- or-none phenomenon in 
The heterogeneity of the schizophrenia phenotype categorical) and that dimensions can overlap in a 
is perhaps the most fundamental problem that given patient. 
clinicians and researchers who study this disorder Dimensional approaches for the study of 
must face. The heterogeneity is cross-sectional, schizophrenia grew out of early attempts to apply 
longitudinal and aetiopathophysiological as well the positive/negative distinction, initially proposed 
in that different neurochemical abnormalities by Hughlin Jackson and later reformulated by Crow 
involving multiple neurotransmitters may be as Type land Type 2 (Crow, 1980). As rating 
preferentially involved in different patients resulting scales were developed that permitted the 
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measurement of a braod range of positive and 
negative symptoms using continuous measures 
(Andreasen, 1982; Andreasen and Olsen, 1982), a 
number of investigators began to apply factor 
analytic and correlational approaches in order to 
examine the interelationships between these 
symptoms (Andreasen and Grove, 1986; Liddle, 
1987; Bilder et al., 1985, Andreasen etal.,1995). 
Most of these studies have shown that the 
symptoms of schizophrenia fall into three 
dimensions: psychoticism. disorganization and 
negative symptoms (Andreasen etsl.,1995). This 
three-dimensional hypothesis still remains the 
most robustly replicated of all competing models 
of schizophrenic psychopathology (Amador and 
Gorman, 1998). 
There is ample evidence from the literature 
to suggest the involvement of amines such as 
Dopamine and Serotonin and their interactions in 
the causation of schizophrenia. After the atypical 
antipsychotics were introduced attention is being 
given to neurochemical basis of schizophrenia. 
These atypical antipsychotics affect both positive 
and negative symptoms and mediate their action 
predominantly thorough dopaminergic and 
serotonergic receptors. There has been great 
interest in the neurobiological substrate of the 
different dimensions of schizophrenia. This has 
largely focused on structural and functional 
changes while it has been acknowledged that there 
is a relation between pharmacological response 
and neurotransmitter alteration on these 
dimensions. The current study extends this further 
looking at CSF amines and their possible 
relationships with the dimensions of schizophrenia. 
Various studies have used techniques of 
measuring amine metabolites in body fluids and 
their possible correlations with symptoms of 
schizophrenia. The present study is aimed at 
finding a correlation between the concentrations 
of dopamine and serotonin and their acid 
metabolites Homo Vannilic Acid (HVA) and 5-
Hydroxy Indole Acetic Acid (5-HIAA) in the 
Cerebro Spinal Fluid in a group of drug naive 
schizophrenics and three dimensions of 
schizophrenia. 
MATERIALS AND METHODS 
The subjects for the present study 
consisted of 37 drug naive patients fulfilling the 
Diagnostic and Statistical Manual of Mental 
Disorders-Fourth Edition (DSM-IV) criteria for 
schizophrenia or schizophreniform disorder 
(American Psychiatric Association,1992). 
Patients were selected for the study between 
December 1998 and September, 1999. Both sexes 
between 17-45 years of age were included. The 
duration of illness varied between 1 month to 2 
years. Patients with the history of any general 
medical disorder, known neurological conditions, 
head injury, Persistent substance use disorders, 
concomitant Axis I or Axis II disorders and 
significant suicidal or homicidal risk were 
excluded from the study. A written informed 
consent was taken from the patients and their 
relatives and the patient was admitted. 
Assessment of the psychopathology was 
carried out using the Scale for the Assessment 
of Positive Symptoms (SAPS) and Scale for the 
Assessment of Negative Symptoms(SANS). The 
scores on each of the three dimensions were 
calculated based on the method described by 
Liddle (1987). The score on the psychotic 
dimension was the sum of items for auditory 
hallucinations commenting on the patient's 
behaviour, persecutory delusions and delucions 
of reference. The score on the disorganization 
dimension was the sum of the scores for items 
measuring inappropirate affect, poverty of content 
of speech and the global rating of positive formal 
thought disorder. The negative dimension was 
scored using items assessing poverty of speech 
, decreased spontaneous movement and the 
average of four items reflecting aspects of blunting 
of affect (affective non-responsivity, unchanging 
facial expressioon, apucity of expressive gestures 
and lack of vocal inflections). Thus the maximum 
score on each of the three dimensions would be 
15. 
Patients were kept off any kind of 
medications till next day morning. Lumbar 
puncture was done between 9.00-9.30 AM with 
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overnight fasting. Lumbar puncture were done in 
left lateral position at L4-5 levels with out using 
local anaesthetic. About 5 ml of clear CSF was 
obtained for the analysis. CSF was collected in a 
bottle and with in 30 minutes was stored at -80° C 
till the day of the analysis. 
Determination of Serotonin [5HT], Dopamine 
[DA], 5- Hydroxy indole acetic acid [5-HIAA], 
Homo vanilic acid [HVA] in CSF was done 
using High Pressure Liquid Chromatography 
[HPLC] with Electrochemical Detection [ED] 
[SHIMADZU, JAPAN], Reverse phase C18 column 
[25cmx4.6cm, pore size-0.5mic] was used for 
separation of the amines and their metabolites at 
room temperature. Mobile Phase [ 20 mM Sodium 
acetate, 1.9mM Haptane sulphonic acid, 1mM 
EDTA, 0.002% Dibutylamine with 16% Methanol 
adjusted at the pH of 3.97] was pumped at 1ml/ 
min flow rate. Biogenic amines and their 
metabolites were detected by measuring the 
current with a glassy carbon electrode at 0.6 volts 
relative to Ag- AgCI reference electrode. 
Standards were Serotonin, Dopamine, HVA and 
HIAA (Sigma, USA). Standards were filtered 
through 0.2 u. Millipore filters and injected onto 
the HPLC col umn. HIAA had a retention time of 
12.8 min, HVA had a retention time of 19.1 min,DA 
had a retention time of 11.5min and 5-HT had a 
retention time of 30.6min. 5 microns of standards 
were injected with every batch of samples. Sample 
preparation included extraction with 3M Per Chloro 
Acetic acid [PCA] and CSF sample were filtered 
through 0.2 u. Millipore filters and treated with 
equal volume of 3 M PCA. The precipitate was 
centrifuged at 10,000 rpm for 15 minutes. The 
supernatant was filtered using 0.2 u, filters. 20u. L 
of the prepared samples were injected in to the 
HPLC in batches along with standard. The values 
of amine and their metabolites obtained were 
expressed as ng/ml (Nielsen and Johnson, 1982). 
Statistical analysis was done using 
Statistical Package for Social Sciences (SPSS), 
version 7.5. A step-wise multiple regression 
analysis was done to assess the relationship 
between score on the three dimensions and the 
levels of monoamines and their metabolites in 
CSF. Only those variables with significant F values 
would enter the relationship between score on the 
three dimensions and the CSF 5 HIAA/HVA ratio. 
Factor analysis with varimax rotation was done 
using amine and their metabolites and three 
dimensional scores. 
RESULTS 
37 Patients meeting the inclusion criteria 
were included in the study. Out of these 
25[67.57%] were males and 12 [32.43%] were 
females. The study sample had a mean age of 
28.62 years. 26 patients were diagnosed as 
Schizophrenia according to DSM IV criteria, and 
11 were diagnosed as Schizophreniform disorder. 
As described in the methodology dimensional 
scores for the 3 dimensions were calculated. 
Table 1 shows Socio demographic data, illness 
characteristics and amine levels. 
TABLE 1 
SOCIO DEMOGRAPHIC DATA, ILLNESS CHARACTER 
ISTICS AND AMINE LEVELS 
TOTAL NUMBER OF PATIENTS (N)-37 
SEX (M:F) 25:12 
Variable Mean SO. Range 
Age 28.62 6.55 17-42 
Age of onset 28.05 6.44 17-40 
Duration of 9.13 7.07 1-24 
illness 
(in month) 
Psychosis 9.24 3.77 2-15 
dimension 
score 
Negative 8.11 4.05 1-15 
dimension 
score 
Disorganization 5.81 3.11 0-11 
dimension score 
C-5HT 7.72 1.65 5.17-12.02 
C-HIAA 25.35 4.39 18.89-39.94 
C-DA 3.06 0.62 2.03-4.51 
C-HVA 36.99 5.65 28.08-51.49 
A step- wise Multiple Regression Analysis 
was done to identify the relationship between the 
score on three dimensions as independent variable 
and the levels of Amines and their metabolites in 
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CSF as dependent variable. A step wise Multiple 
Regression Analysis was also done with the levels 
of Amines and their metabolites in CSF as 
independent variable, scores on three dimensions 
as dependent variable. Ratio of 5HIAA/HVA was 
calculated. A step wise Multiple Regression 
Analysis was done to identify the relationship 
between the score on three dimensions as 
indpendent variable and 5HIAA/HVA ratio as 
dependent varibale. 
TABLE 2 
MULTIPLE REGRESSION FOR CSF 5HIAA 
Criteria: P-l n. 0500, P-Out. 1000 
Dependent Variable: CHIAA 
Independent Variable: Disorganization, Negative, 
Psychosis 
Variables (s) Entered on Step Number 1. Disorganization 
Multiple R 
.49047 
R Square 
.24056 
Adjusted 
R Square 
.21886 
F=1.08671 
Standard 
Error 
3.87963 
; Sig F=.0021 
TABLE 3 
MULTIPLE REGRESSION FOR NEGATIVE DIMENSION 
Criteria; P-ln .0500, P-Out .1000 
Dependent Variable: Negative 
Independent Variable: C-5HT, C-DA, C-HIAA, C-HVA 
Variables (s) Entered on Step Number 1. C-HIAA 
Multiple R R Square Adjusted Standard 
R Square Error 
.38362 .14717 .12280 3.80028 
F=03971; Sig F=.0191 
Disorganization dimension accounted for 
0.241 % of the variance in CSF-5HIAA level-as 
obtained by step-wise multiple regression 
analysis. Psychosis and negative dimensions did 
not enter the regression equation (Table 2). CSF-
5HIAA accounted for 0.147% of the variance in 
} Negative dimension as obtained by step-wise 
multiple regression analysis. Other amines and 
their metabolites did not enter the regression 
equation (Table 3). Disorganization dimension 
accounted for 0.109% of the variance in CSF-
5HIAA/HVA ratio levels as obtained by step-wise 
multiple regression analysis. Psychosis and 
negative dimensions did not enter the regression 
equation (Table 4). Other multiple regression 
models did not reveal any significant results. 
TABLE 4 
MULTIPLE REGRESSION FOR CSF 5HIAA/HVA RATIO 
Criteria: P-ln .0500, P-Out. 1000 
Dependent Variable: HIAA/HVA RATIO 
Independent Variable: Disorganization, Negative 
Psychosis 
Variables (s) Entered on Step Number 1. Disorganization 
Multiple R R Square Adjusted Standard 
R Square Error 
.33012 .10898 .08352 .160524 
F=2809; Sig F= 0460 
TABLE S 
FACTOR ANALYSIS 
AMINES AND THEIR METABOLITES AND THREE 
DIMENSIONAL SCORES ROTATED FACTOR MATRIX 
Variable 
C-5HT 
C-DA 
C-HIAA 
C-HVA 
Disorganization 
Negative 
Psychosis 
Eigenvalue 
Pet of Var 
Factor I 
.115 
.036 
.616 
.053 
.909 
.863 
-.592 
2.48193 
22.6 
Factor 2 
.728 
.714 
.392 
-.609 
.016 
.062 
.410 
1 93700 
17.6 
Factor 3 
-.137 
-.053 
.012 
-.416 
-.049 
.032 
.032 
1.56713 
14.2 
CSF 
CDA 
C5HT 
C5HIAA 
CHVA 
StdD 
Pet Var 
LIST OF ABBREVIATIONS 
Cerebro Spinal Fluid 
CSF Dopamine 
CSF Serotonin 
CSF 5 Hydroxy Indole Acetic Acid 
CSF Homo Vanillic Acid 
Standard Deviation 
Percentage of Variance 
A factor Analysis with Varimax Rotation 
was done to find the relationship between the score 
on three dimensions and the levels of Amines and 
their metabolites in CSF as variables Scores of 
3 dimensions of schizophrenia and the levels of 
amines and their metabolites in CSF were used 
for factor analysis and three factors were 
extracted. The initial factor solutions were 
subjected to varimax rotation. CSF 5HIAA, 
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Disorganization and Negative dimensions load on 
the first factor. Psychosis dimension had 
significant negative correlation . In factor two 
psychosis dimension had negative correlation with 
CSF HVA. Table 5 shows the factor analysis. 
DISCUSSION 
Screening of 37 drug naive patients with 
the presence of strict inclusion and exclusion 
criteria meant that a relatively 'clean' sample of 
patients was obtained for the study. Inclusion of 
drug naive patients for the study ruled out the effect 
of any psychotropic medication's ability to alter 
the concentratioon of biogenic amines and their 
metabolites in the CSF. The sample had relatively 
short mean illness duration . The maximum 
duration of illness was kept at 2 years. This has 
largely avoided the effect of chronicity on the levels 
of amines and their metabolites in CSF. 
Psychopathology was rated on SAPS and SANS. 
Both the instruments have been well studied and 
validated. The dimension scores were calculated 
using the method described by Liddle (1987). 
Lumbar puncture (LP) was done at the same time 
of the day after an overnight fasting for all patients. 
All LPs were done at the level between L4-5 space 
in left lateral position. This uniformity in the CSF 
sampling largely avoided any variation in the level 
of amines and their metabolites including the site 
of lumbar puncture, diurnal variation, and diet. 
This study attempted to find the possible 
relationship between three dimensions of 
schizophrenia and their neurochemical 
involvement concentrating on Dopamine and 
Serotonin and their interaction in causing various 
symptoms of schizophrenia. This study selected 
measuring both Dopamine and Serotonin and thier 
metabolites since both of these amines are often 
implicated in the pathophysiology schizophrenia. 
The current study consistently shows a 
strong correlation between CSF 5HIAA and 
disorganization dimension of schizopohrenia. Only 
disorganization dimension entered the multiple 
regression with CSF 5HIAA. In factor analysis both 
CSF 5HIAA and disorganization loaded in factor 
1. Factor analysis provides support to the close 
asssociation between CSF 5-HIAA and 
disorganization dimension. Regression analysis 
also showed significant positive correlation 
between CSF HIAA/HVA ratio and 
Disorganization dimension.This further supports 
the relationship between CSF 5HIAA and 
Disorganization dimension. Bowers et al.(1973) 
found positive correlation between CSF 5HIAA 
levels and scores related to psychotic 
disorganization of mental content. Bowers & 
Rozitis (1974) also found positive correlation 
between CSF 5HIAA/HVA ratio with first rank 
symptoms of schizophrenia. King et al.(1985) in 
a group of schizophrenic patietns found that the 
level of CSF 5HIAA correlates positively with 
mannerisms and posturing, but these symptoms 
co-vary with other negative symptoms. The 
significant positive correlation between CSF 
5HIAA and disorganization dimension, which 
emerged consistently from this study, is 
interesting and provides evidence for the possible 
involvement of serotonin in the patho-physiology 
of the disorganization dimension. 
The results of this study also show a clear 
association between CSF 5-HIAA and Negative 
dimension of schizophrenia. This finding is 
consistent with previous findings. Kirstein et 
al.[1976] found inverse correlation between CSF 
5HIAA levels and psychomotor agitation in 
schizophrenic patients. Bowers (1975) 
demostrated inverse correlation between CSF 5 
HIAA levels and favorable prognostic signs, acute 
course and low levels of emotional withdrawal. 
Csernansky et al.(1990) has also found a positive 
correlation between CSF 5HIAA and various deficit 
symptoms of schizophrenia. Data from literature 
indicates that higher concentration of 5-HIAA may 
be associated with negative symptoms and 
chronicity within a group of schizophrenic patients. 
Findings from this study add support to the 
hypothesis that serotonin plays an important role 
in schizophrenia in particular serotonin function 
within the normal range may be linked to negative 
symptoms of this heterogeneous disorder. 
This study also shows significant 
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correlations between psychosis dimension and 
the levels of amines and their metabolites in the 
CSF. In factor analysis CSF 5HIAA correlates 
negatively with psychosis dimension. This is 
consistent with studies by others showing low 
levels of CSF HIAA in patients with First Rank 
symptoms (Post, et al.,1975) and with the 
presence of delusions (Lindstrom, 1985). 
In factor analysis CSF HVA levels correlated 
negatively with psychosis dimension. This is 
consistent with the previous studies. Bowers et 
al.(1973) reported low CSF HVA in patient with 
first rank symptoms. He also reported low CSF 
HVA associated with poor prognosis. Post et 
al.(1975) also demonstrated low CSF HVA in 
patients with First Rank symptoms. Picker et 
al.(1990) found negative correlation between CSF 
HVA and positive symptoms. They suggest CSF 
HVA levels may relate to frontal cortical 
dopaminergic activity. The possibility that the 
frontal cortical dopaminergic system may 
contribute significantly to HVA levels in CSF could 
have important implications in interpreting the 
negative correlations between CSF HVA and 
psychosis dimension in this study, since there is 
evidence to show that CSF HVA at least partially 
reflect frontal cortex dopamine activity. This is 
consistent with the "bi-directional" model of 
psychosis postulated by Pickec et al.(1990) that 
decreased frontal cortical release or metabolism 
of DA could be coupled with increased sub 
cortical activity resulting in positive symptoms of 
schizophrenia. 
This study also showed positive correlation 
between CSF Dopamine and psychosis 
dimension. Previous studies measured 
predominantly the levels of HVA rather than 
Dopamine in CSF. High level of CSF HVA has 
been positively correlated in one study with 
paranoid symptoms (Rimon et al.,1971). It can 
be argued that the CSF Dopamine originates 
predominantly in the striatum adjacent to lateral 
ventricles and is thought to reflect nigrostriatal 
dopaminergic activity. This can explain the sub 
cortical hyperdopaminergia in producing psychotic 
symptoms. The negative correlation between CSF 
HVA and CSF Dopamine in the current study is a 
contradictory finding in the methodology in 
measuring Dopamine and its metabolite HVA in 
CSF. 
Measurement of amines and their 
metabolites in the body fluids to certain extent 
reflects the central metabolism of the parent 
amine. The central origin of CSF HVA has been 
clearly established and to certain extent for CSF 
5HIAA as well even though it has significant spinal 
cord origin. CSF HVA has been clearly 
established to originate from striatum adjacent 
to lateral ventricle. Recently it has been suggested 
following clinical studies the CSF HVA at least 
partially reflects frontal cortex Dopamine activity. 
This has important implications in interpreting the 
negative correlation between CSF HVA and 
psychosis dimension found in this study. This 
study provides support ot the existing hypothesis 
that hypodopaminergia in mesocortical dopamine 
neurons results in increased sub cortical 
dopamine activity result in psychotic symptoms. 
Negative symptoms of schizophrenia have 
been linked to frontal dysfunction. It has also been 
suggested that this frontal dysfunction reflect 
atleast in part hypodopaminergia in frontal cortex. 
Serotonin has an inhibitory influence on the 
dopaminergic neurons at the level of substantia 
nigra and cortex. The finding of positive correlation 
between CSF 5HIAA and Negative dimension 
coupled with the finding of negative correlation 
between CSF HVA and psychosis dimension 
provides evidence that increased levels of 
Serotonin inhibits dopaminergic neurons in frontal 
cortex results in negative symptoms. This 
Serotonin- Dopamine interaction at different level 
is clinically relevant since atypical antipsychotic 
medications alter the imbalance between 
Serotonin and Dopamine there by relieves negative 
symptoms in schizophrenia. 
This study has explored the differential 
effects of Dopamine and Serotonin with dimensions 
of schizophrenia psychopathology. Serotonin 
seems to be implicated in the dimension studied 
with CSF 5HIAA being associated with 
disorganization and negative symptoms, and 
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negatively linked with the psychotic dimension. 
The psychotic dimension is in addition implicated 
with both Serotonin and Dopamine, and negatively 
with the Dopamine metabolite HVA. This study 
suggests that there is an increased frontal 
serotonergic tone as the neurobiological basis for 
both disorganization and negative symptoms. A 
hyperdopaminergic state substrate is suggested 
for the psychotic dimension. The differential 
neurochemical involvement in the dimensions of 
schizophrenia suggests an apt model to explore 
the mechanism of action of atypical antipsychotic 
and their wide spectrum of therapeutic efficacy. 
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